Mammalian Display Platform for Antibody Discovery

About InSCREENeX

InSCREENeX is a privately held, revenue-generating service provider in the drug discovery tools space, focusing on engineered cell lines. The company's core offerings are highly customized stable cell line generation and cell immortalization services, which are critical for target validation, antibody discovery, and toxicity testing in pharmaceutical R&D. It has established a strategic collaboration with YUMAB for platform development and operates from a prestigious research institute, indicating strong scientific credibility. While primarily a service business, its proprietary cell engineering technologies position it as a potential platform company for future therapeutic discovery partnerships.